{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:48:36Z","timestamp":1783424916954,"version":"3.54.6"},"reference-count":21,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2025,3,25]]},"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1136\/ejhpharm-2025-004475","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T13:20:27Z","timestamp":1744982427000},"page":"387-390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Severe coagulation dysfunction and active bleeding induced by cefoperazone\/sulbactam in a patient with severe renal insufficiency: a case report"],"prefix":"10.1136","volume":"33","author":[{"given":"Jiayuan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[{"name":"Trauma Center, Department of Orthopaedics and Traumatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9814-1167","authenticated-orcid":false,"given":"Xuehui","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"2026062306251108000_33.4.387.1","first-page":"76","article-title":"Cefoperazone in the treatment of severe or complicated infections","volume":"22 Suppl 1","author":"Bailey","year":"1981","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026062306251108000_33.4.387.2","first-page":"52","article-title":"Cefoperazone-sulbactam combination in the treatment of urinary tract infections: efficacy, safety, and effects on coagulation","volume":"10","author":"Greenberg","year":"1987","journal-title":"Clin Ther"},{"key":"2026062306251108000_33.4.387.3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijantimicag.2015.12.019","article-title":"Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China","volume":"47","author":"Ouyang","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2026062306251108000_33.4.387.4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/sur.2007.013","article-title":"Cefoperazone-Sulbactam for Treatment of Intra-Abdominal Infections: Results from a Randomized, Parallel Group Study in India","volume":"9","author":"Chandra","year":"2008","journal-title":"Surg Infect (Larchmt)"},{"key":"2026062306251108000_33.4.387.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158407","article-title":"Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"2026062306251108000_33.4.387.6","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.20449","article-title":"Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency","volume":"81","author":"Wong","year":"2006","journal-title":"Am J Hematol"},{"key":"2026062306251108000_33.4.387.7","unstructured":"LiverTox: clinical and research information on drug-induced liver injury. Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury. Bethesda (MD) National Institute of Diabetes and Digestive and Kidney Diseases; 2019."},{"key":"2026062306251108000_33.4.387.8","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1988.tb03106.x"},{"key":"2026062306251108000_33.4.387.9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.6.1108"},{"key":"2026062306251108000_33.4.387.10","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1043971","article-title":"Assessment of the impact of intravenous antibiotics treatment on gut microbiota in patients: Clinical data from pre-and post-cardiac surgery","volume":"12","author":"Xue","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2026062306251108000_33.4.387.11","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16203937","article-title":"The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis","volume":"16","author":"Park","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2026062306251108000_33.4.387.12","doi-asserted-by":"publisher","DOI":"10.1177\/1076029611430955"},{"key":"2026062306251108000_33.4.387.13","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s11096-019-00912-5","article-title":"Tigecycline-induced coagulopathy: a literature review","volume":"41","author":"Cui","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"2026062306251108000_33.4.387.14","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/clinids\/5-Supplement_1.S127","article-title":"Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function","volume":"5 Suppl 1","author":"Greenfield","year":"1983","journal-title":"Rev Infect Dis"},{"key":"2026062306251108000_33.4.387.15","first-page":"35","article-title":"Pharmacokinetics of cefoperazone: a review","volume":"22 Suppl 1","author":"Craig","year":"1981","journal-title":"Drugs (Abingdon Engl)"},{"key":"2026062306251108000_33.4.387.16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90256-1"},{"key":"2026062306251108000_33.4.387.17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00228-016-2045-x","article-title":"Pharmacokinetics of cefoperazone\/sulbactam in critically ill patients receiving continuous venovenous hemofiltration","volume":"72","author":"Gao","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"2026062306251108000_33.4.387.18","first-page":"78","article-title":"Analysis on factors affecting dysfunction of blood coagulation caused by cefoperazone sodium-sulbactam sodium","volume":"15","author":"Li","year":"2018","journal-title":"Chin J Ration Drug Use"},{"key":"2026062306251108000_33.4.387.19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/00185787241238310","article-title":"Cefoperazone-Sulbactam-Induced Coagulopathy in Critically Ill Egyptian Patients: Role of Vitamin K Prophylactic Doses","volume":"59","author":"Ebid","year":"2024","journal-title":"Hosp Pharm"},{"key":"2026062306251108000_33.4.387.20","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1016\/j.clinthera.2021.10.005","article-title":"A Comparison of Coagulation Function in Patients Receiving Aspirin and Cefoperazone-Sulbactam With and Without Vitamin K1: A Retrospective, Observational Study","volume":"43","author":"Wu","year":"2021","journal-title":"Clin Ther"},{"key":"2026062306251108000_33.4.387.21","first-page":"668","article-title":"Coagulopathy in the surgical patient: trauma-induced and drug-induced coagulopathies","volume":"25","author":"Peralta","year":"2019","journal-title":"Curr Opin Crit Care"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:25:48Z","timestamp":1782221148000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6,23]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/ejhpharm-2025-004475"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004475","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}